Detalhe da pesquisa
1.
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.
N Engl J Med
; 376(4): 330-341, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25830322
2.
Comparative evaluation of pathogenicity of three isolates of vesicular stomatitis virus (Indiana serotype) in pigs.
J Gen Virol
; 100(11): 1478-1490, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553299
3.
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission.
Emerg Microbes Infect
; 10(1): 651-663, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719915
4.
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment.
Vaccine X
; 1: 100009, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384731
5.
Regulation of the C5a receptor promoter in glial cells: Minimal dependence upon the CCAAT element in astrocytes.
Mol Immunol
; 44(5): 713-21, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16750856
6.
Transcriptional control of the C3a receptor gene in glial cells: Dependence upon AP-1 but not Ets.
Mol Immunol
; 44(5): 703-12, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16854466
7.
Transcriptional control of complement receptor gene expression.
Immunol Res
; 39(1-3): 146-59, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17917062
8.
Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.
PLoS One
; 12(8): e0182683, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787006
9.
Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.
Lancet Infect Dis
; 17(8): 854-866, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28606591
10.
Transcriptional regulation of the murine C5a receptor gene: NF-Y is required for basal and LPS induced expression in macrophages and endothelial cells.
Mol Immunol
; 42(11): 1405-15, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15950736
11.
Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis.
Neurosci Lett
; 390(3): 134-8, 2005 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16154690
12.
c-Jun and c-Fos regulate the complement factor H promoter in murine astrocytes.
Mol Immunol
; 49(1-2): 201-10, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21920606
13.
Transcriptional control of genes for soluble complement cascade regulatory proteins.
Mol Immunol
; 48(1-3): 9-13, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20869772
14.
CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model.
Mol Immunol
; 48(1-3): 219-30, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20813409
15.
Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles.
J Virol Methods
; 169(2): 259-68, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20655330
16.
A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge.
Virology
; 397(1): 187-98, 2010 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19932911
17.
Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.
Glia
; 55(14): 1405-15, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17674370
18.
Characterization of the murine C3a receptor enhancer-promoter: expression control by an activator protein 1 sequence and an Ets-like site.
J Immunol
; 175(5): 3123-32, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16116202
19.
Expression of complement protein C5a in a murine mammary cancer model: tumor regression by interference with the cell cycle.
Cancer Immunol Immunother
; 54(10): 1026-37, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15868168